Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agonist Replacement for Stimulant Dependence: A Review of Clinical Research
William W. Stoops, Craig R. Rush
Current Pharmaceutical Design (2013) Vol. 19, Iss. 40, pp. 7026-7035
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Dropout rates of in‐person psychosocial substance use disorder treatments: a systematic review and meta‐analysis
Sara Lappan, Andrew W. Brown, Peter S. Hendricks
Addiction (2019) Vol. 115, Iss. 2, pp. 201-217
Closed Access | Times Cited: 254
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
Erin A. McClure, Cassandra D. Gipson, Robert Malcolm, et al.
CNS Drugs (2014) Vol. 28, Iss. 2, pp. 95-106
Open Access | Times Cited: 182
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
Vítor S. Tardelli, Adam Bisaga, Felipe B. Arcadepani, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2233-2255
Closed Access | Times Cited: 111
Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial
Elias Dakwar, Carl L. Hart, Frances R. Levin, et al.
Molecular Psychiatry (2016) Vol. 22, Iss. 1, pp. 76-81
Open Access | Times Cited: 76
Agonist Medications for the Treatment of Cocaine Use Disorder
S. Stevens Negus, Jack E. Henningfield
Neuropsychopharmacology (2014) Vol. 40, Iss. 8, pp. 1815-1825
Open Access | Times Cited: 70
Pharmacotherapy for amphetamine dependence: A systematic review
Nicole K. Lee, Linda Jenner, Angela Harney, et al.
Drug and Alcohol Dependence (2018) Vol. 191, pp. 309-337
Closed Access | Times Cited: 64
Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?
Laura Brandt, Thomas Chao, Sandra D. Comer, et al.
Addiction (2020) Vol. 116, Iss. 4, pp. 694-710
Open Access | Times Cited: 64
Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors
Jianjing Cao, Rachel D. Slack, Oluyomi M. Bakare, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10676-10691
Open Access | Times Cited: 63
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers
Margaret Haney, Divya Ramesh, Andrew Glass, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 11, pp. 2489-2498
Open Access | Times Cited: 62
Monoamine Transporter Inhibitors and Substrates as Treatments for Stimulant Abuse
Leonard L. Howell, S. Stevens Negus
Advances in pharmacology (2014), pp. 129-176
Open Access | Times Cited: 56
What Differentiates Dropping Out from Remaining in a Brief Intervention for Problematic and Dependent Methamphetamine Users?
Magdalena Rowicka
Journal of Psychoactive Drugs (2025), pp. 1-9
Closed Access
Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence
Kenneth M. Dürsteler, Eva-Maria Berger, Hannes Strasser, et al.
Substance Abuse and Rehabilitation (2015), pp. 61-61
Open Access | Times Cited: 46
Use of Preclinical Drug Vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction
Matthew L. Banks, Blake A. Hutsell, Kathryn L. Schwienteck, et al.
Current Treatment Options in Psychiatry (2015) Vol. 2, Iss. 2, pp. 136-150
Open Access | Times Cited: 46
Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure
Matthew L. Banks, Blake A. Hutsell, Bruce E. Blough, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 8
Open Access | Times Cited: 42
Risk factors for stimulant use among homeless and unstably housed adult women
Elise D. Riley, Martha Shumway, Kelly R. Knight, et al.
Drug and Alcohol Dependence (2015) Vol. 153, pp. 173-179
Open Access | Times Cited: 40
Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys
Matthew L. Banks, Bruce E. Blough, S. Stevens Negus
Drug and Alcohol Dependence (2013) Vol. 131, Iss. 3, pp. 204-213
Open Access | Times Cited: 40
Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research
William W. Stoops, Craig R. Rush
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 3, pp. 363-374
Open Access | Times Cited: 34
Differential sensitivity to learning from positive and negative outcomes in cocaine users
Justin C. Strickland, B. Levi Bolin, Joshua A. Lile, et al.
Drug and Alcohol Dependence (2016) Vol. 166, pp. 61-68
Open Access | Times Cited: 29
Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse
Justin C. Strickland, Cassandra D. Gipson, Kelly E. Dunn
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 14
Development of a translational model to screen medications for cocaine use disorder I: Choice between cocaine and food in rhesus monkeys
Amy R. Johnson, Matthew L. Banks, Bruce E. Blough, et al.
Drug and Alcohol Dependence (2016) Vol. 165, pp. 103-110
Open Access | Times Cited: 25
Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol
Joshua A. Lile, Michael J. Wesley, Thomas H. Kelly, et al.
Behavioural Pharmacology (2015) Vol. 27, Iss. 2 and 3 - Special Issue, pp. 215-224
Open Access | Times Cited: 22
Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS
Rahul Dev Jayant, Venkata Atluri, Sneham Tiwari, et al.
Journal of NeuroVirology (2017) Vol. 23, Iss. 4, pp. 603-614
Open Access | Times Cited: 21
Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir
Shilpa Sonti, Kratika Tyagi, Amit Pande, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 202-202
Open Access | Times Cited: 11
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.
Matthew L. Banks, Clayton T. Bauer, Bruce E. Blough, et al.
Experimental and Clinical Psychopharmacology (2014) Vol. 22, Iss. 3, pp. 274-284
Open Access | Times Cited: 19
Methamphetamine Self-Administration in Humans During d-Amphetamine Maintenance
Erika Pike, William W. Stoops, Lon R. Hays, et al.
Journal of Clinical Psychopharmacology (2014) Vol. 34, Iss. 6, pp. 675-681
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top